3 Promising Income Stocks

By Mijuško Šibalić, Stock Market Writer and Stock Researcher
November 19, 2025 5:57 AM UTC
3 Promising Income Stocks

The longest government shutdown in U.S. history has concluded — and soon, investors will receive the economic data that has thus far been delayed. 

Whether the news will be good or bad remains to be seen, but a partial slowdown is to be expected. The Congressional Budget Office estimates that GDP growth in Q4 will suffer by as much as 1.5% percentage points.

So, where does this leave the average investor? 

You can expect shifts and rotations as we head into December, but the smart money crowd has already changed its posture. They’ve gone a bit more defensive — away from tech and cyclicals and toward asset-heavy sectors.

It makes sense — with valuations already stretched after a three-year bull market, and receding odds of a rate cut, these stable companies with mature business models become more appealing on account of both dividends and potential capital gains.

Mirroring that move with your portfolio is the way to go. The only question that’s left is how to identify the right stocks to invest in. Thankfully, the answer isn’t complicated — you simply turn to our…

Income Stock Strategy

Our quant rating system evaluates roughly 4,600 stocks on a daily basis using a robust framework of 115 proprietary factors. Those insights are boiled down to a single, straightforward metric — our renowned Zen Ratings.

The top 5% of stocks are given a Zen Rating of A, equivalent to a Strong Buy rating. While that’s a great start, it still leaves somewhere in the ballpark of 230 stocks for you to consider.

So, how can you narrow down the search even further? By taking a look at our Zen Strategies.

Each of these 11 portfolios consists of just 7 rigorously selected, carefully vetted stocks in order to provide market-beating returns.

Today, you’ll get a sneak peek at a portfolio that has an all-time annual return of 25.08%. It has already outperformed the market by 13.34% in 2025 — and 6.10% of that came in November alone, so it’s gearing up for a strong finish. It is, of course, our Income Stock Strategy.

Since there’s no reason to believe the bull market will end any time soon, you want to strike a balance between growth potential, solid financials, stable dividends, and valuation. Without further ado, here are 3 stocks to keep your eye on…

HF Sinclair (DINO)

Our first entry, HF Sinclair, is a $10.3 billion oil & gas juggernaut with a Zen Rating of A. DINO currently ranks as the 39th highest-rated stock overall on our list — near the top of the top 1%. It’s also the 3rd highest-rated stock in the Oil & Gas Refining & Marketing industry, which has an Industry Rating of A — as well as the largest stock in the industry with a Zen Rating of A.

DINO maintains a consistent dividend payment, currently at a forward yield of 4.34%,  which has steadily increased over the past 10 years without major hiccups. Earnings are expected to show a healthy growth rate of 27.79% per year, putting HF Sinclair in the top 7% in terms of the Growth Component Grade rating. At a modest P/E of 26.37x and a PEG ratio of 0.95x, it also ranks in the top 24% when it comes to Value.

Thanks to healthy cash flow, shrinking debt, and an impressive war chest of short-term assets, the stock also ranks in the top 17% with regard to Financials. In addition, a neural network trained on two decades of market data has singled it out as a likely outperformer — which brings us to DINO’s strongest rating, Artificial Intelligence, where it ranks in the top 5%.

Bristol Myers Squibb (BMY)

The next stock you should take a look at is Bristol Myers Squibb. BMY is a $94.97 billion pharma titan that ranks in the top 2% of the stocks that we track. It’s also the 2nd highest-rated stock in the General Drug Manufacturer Industry, which has an Industry Rating of A and is currently the 3rd highest-rated industry out of a total of 145.

BMY’s forward dividend yield stands at 5.46% — and the distributions have, like in the case of our previous pick, steadily increased without dips in the past 10 years. Earnings are forecast to grow at 25.52% per year, placing Bristol Myers Squibb in the top 13% in Growth — while a P/E of 15.71x and PEG ratio of 0.62x place it in the top 3% with regard to Value.  Simply put, right now, it’s a steal.

Per our Artificial Intelligence rating, BMY ranks in the top 8% of stocks. To cap it all off, it also ranks in the top 10% for Financials and the top 5% for Safety — so there’s no shortage of virtues here.

TIM S.A. (TIMB)

The last stock we put forward for your consideration is Brazilian telecom giant Tim S.A. The $11.34 billion market cap company is in the top 1% of the stocks that we track, and currently ranks 40th overall out of roughly 4,600.

TIMB’s earnings are forecast to grow by 24.91% per year — and revenues are forecast to grow by 90.17% per year. That places it in the top 20% for Growth — and should make up for the fact that it has a less stable dividend compared to DINO and BMY. At a P/E of 20.77x and a PEG ratio of 0.83x, it also ranks in the top 17% for Value.

TIM S.A. shares also rank in the 93rd percentile in terms of Momentum — which isn’t surprising once you learn it has beaten estimates for 3 consecutive quarters, which has led to a 96.96% year-to-date gain. Lastly, like our previous sentry, TIMB boasts an impressive balance sheet and the seal of approval from our neural network, as it ranks in the top 5% of stocks for both Financials and Artificial Intelligence.

Interested In More Great Stock Picks?

The 3 stocks highlighted above are just a fraction of what you get from our proven Income stock strategy

That’s because each day our system recalibrates — and Zen Strategies members get access to the top 7 income stocks based on 115 different parameters that point to outperformance. 

See all Top 7 Income stocks here > 

However, maybe you want more than just income stocks. Perhaps you would like to see all 11 of our market beating strategies including Growth, Value, Momentum and our coveted AI Factor model. 

Each featuring the top 7 stocks.

Each featuring tremendous performance

We spell it all out in this timely presentation below that lives up to its name:

10 Minutes a Month to Beat the Market > 

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.